Cardio Diagnostics Holdings Inc. Common stock

CDIONASDAQ • USD
1.72 USD
↗ 0.03 (1.78%)AT CLOSE (03:59 PM EDT)
1.68
↘ 0.04 (2.33%)
POST MARKET (AS OF 06:02 PM EDT)
Post Market
AS OF 06:02 PM EDT
1.68
↘ 0.04 (2.33%)
🔴Market: CLOSED

CDIO is currently priced at $1.73. The technical outlook is "Strong Sell" and the fundamental picture shows "Neutral". Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 1/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. Valuation metrics place CDIO at a fair price relative to peers.

Technical & fundamental data as of Oct 26, 2026.

Open?$1.77
High?$1.77
Low?$1.69
Prev. Close?$1.69
Volume?5.9K
Avg. Volume?31.3K
VWAP?$1.73
Rel. Volume?0.19x
Bid / Ask
Bid?$1.55 × 100
Ask?$1.89 × 100
Spread?$0.34
Midpoint?$1.72
Valuation & Ratios
Market Cap?5.0M
Shares Out?3.0M
Float?2.7M
Float %?90.2%
P/E Ratio?N/A
P/B Ratio?0.67
EPS?-$2.19
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Cardio Diagnostics Holdings Inc is a medical technology company focused on developing and commercializing epigenetics-based clinical tests for cardiovascular diseases and associated comorbidities by leveraging its Artificial Intelligence (AI)-driven Multi-Omics Engine. The company has developed two clinical products: Epi+Gen CHD and PrecisionCHD, epigenetics-based clinical blood tests capable of assessing risk for a coronary heart disease (CHD) event, including heart attacks. Additionally, its portfolio includes HeartRisk, a cardiovascular disease risk intelligence platform, and CardioInnovate360, a research-use-only solution launched to support the discovery, development, and validation of novel biopharmaceuticals for the assessment and management of cardiovascular diseases.
Employees
17
Market Cap
5.0M
Industry
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Listed
2022-10-26
Address
311 W. SUPERIOR STREET
CHICAGO, IL 60645
Phone: 855-226-9991
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-2/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
6
Z-Score?
0
Momentum?
77
Short Sent.?
80
Piotroski F-Score?1/9Weak
Altman Z-Score?-1.55Distress
Confidence?46%Low
Full Fundamental Analysis →
Short InterestLow
Short % of Float?0.11%Low
Short Interest?3.0K
Days to Cover?1.0
Free Float2.7M
Avg Daily Volume31.9K
Settlement Date2026-10-15
Financial Health
Current Ratio?17.15Strong
Quick Ratio?17.15Strong
Cash Ratio?15.55Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
83/100
P/E?
N/A▾
P/B?
Peers
100
S&P
97
0.67CHEAP▾
P/S?
Peers
100
S&P
3
346.12HIGH▾
P/FCF?
N/A▾
EV/EBITDA?
Peers
100
S&P
97
0.1CHEAP▾
EV/Sales?
S&P
97
-40.50CHEAP▾
Returns & Efficiency
ROE?
S&P
3
-87.1%WEAK▾
ROA?
S&P
3
-81.6%WEAK▾
Cash Flow & Enterprise
FCF?$-5824437
Enterprise Value?$-585194
Fundamentals ratios updated end of day